Table 1.
Baseline clinical characteristics of patients
| Characteristic* | HPT (n = 66) | PTH (n = 56) | PT (n = 41) | P value |
|---|---|---|---|---|
| Age | 52 (40–65) | 52 (41–64) | 57 (47–67) | 0.074 |
| Gender | 0.416 | |||
| Male | 57 (86.36) | 51 (91.07) | 34 (82.93) | |
| Female | 9 (13.64) | 5 (8.93) | 7 (17.07) | |
| PS | 0.191 | |||
| 0 | 11 (16.67) | 2 (3.57) | 7 (17.10) | |
| 1 | 50 (75.76) | 50 (89.29) | 31 (75.60) | |
| 2 | 5 (7.58) | 4 (7.14) | 3 (7.30) | |
| BMI | 21.64 ± 3.07 | 21.09 ± 2.87 | 22.36 ± 3.42 | 0.135 |
| HBV | 0.191 | |||
| Negative | 12 (18.18) | 4 (7.14) | 5 (12.20) | |
| Positive | 54 (81.82) | 52 (92.86) | 36 (87.80) | |
| Child–pugh | 0.995 | |||
| A | 50 (75.76) | 42 (75.00) | 31(75.60) | |
| B | 16 (24.24) | 14 (25.00) | 10 (24.40) | |
| AFP | 0.199 | |||
| < 400 | 39 (59.09) | 28 (50) | 20 (48.78) | |
| ≥ 400 | 27 (40.91) | 28 (50) | 21 (51.22) | |
| WBC | 5.36 ± 2.20 | 5.83 ± 2.36 | 5.42 ± 2.08 | 0.475 |
| HB | 129.33 ± 21.99 | 130.16 ± 23.10 | 125.12 ± 22.53 | 0.519 |
| PLT | 149.90 ± 82.67 | 166.20 ± 88.09 | 162.39 ± 133.52 | 0.642 |
| LYM | 1.02 ± 0.52 | 1.13 ± 0.52 | 1.05 ± 0.46 | 0.516 |
| TBIL | 21.95 ± 14.53 | 22.06 ± 21.13 | 22.62 ± 22.83 | 0.984 |
| ALT | 71.43 ± 60.36 | 81.45 ± 65.30 | 68.03 ± 48.59 | 0.494 |
| AST | 48.36 ± 38.23 | 51.43 ± 41.95 | 41.86 ± 32.24 | 0.471 |
| ALB | 38.83 ± 7.98 | 36.76 ± 6.75 | 36.44 ± 5.34 | 0.14 |
| LDH | 234.39 ± 156.42 | 326.23 ± 699.87 | 226.84 ± 128.55 | 0.414 |
| PT | 12.31 ± 1.67 | 12.23 ± 1.84 | 12.52 ± 1.37 | 0.701 |
| Liver cirrhosis | 0.231 | |||
| Absent | 44 (66.67) | 43 (76.79) | 33 (80.50) | |
| Present | 22 (33.33) | 13 (23.21) | 8 (19.50) | |
| Tumor thrombus | 0.777 | |||
| Absent | 41 (62.12) | 29 (51.79) | 25 (61.00) | |
| Branch of portal vein | 4 (6.06) | 3 (5.36) | 2 (4.90) | |
| Main portal vein | 21 (31.82) | 24 (42.86) | 14 (34.1) | |
| Extrahepatic metastasis | 0.328 | |||
| Absent | 37 (56.06) | 27 (48.21) | 17 (41.5) | |
| Present | 29 (43.94) | 29 (51.79) | 24 (58.5) | |
| Smoker | 0.994 | |||
| Never | 48 (72.72) | 40 (71.43) | 29 (70.70) | |
| Previous | 9 (13.64) | 7 (12.50) | 6 (14.60) | |
| Now | 9 (13.64) | 9 (16.07) | 6 (14.60) | |
| Alcoholism | 0.403 | |||
| Never | 49 (74.24) | 47 (83.93) | 34 (82.90) | |
| Previous | 9 (13.64) | 6 (10.71) | 2 (4.90) | |
| Now | 8 (12.12) | 3 (5.36) | 5 (12.20) | |
| Surgery | 0.653 | |||
| Yes | 18 (27.27) | 17 (30.36) | 9 (22.00) | |
| No | 48 (72.73) | 39 (69.64) | 32 (78.00) | |
| Radiotherapy | 0.827 | |||
| Yes | 9 (13.64) | 6 (10.71) | 6 (14.60) | |
| No | 57 (86.36) | 50 (89.29) | 35 (85.40) |
HPT initial hepatic artery intervention combined with immunotarget therapy; PTH immunotarget therapy sequential hepatic artery interventional therapy; PT immunotarget therapy only
*No (%)